Orion - Company Announcement

Orion Corporation: Organising meeting of the Board of Directors

ORION  CORPORATION        STOCK EXCHANGE  RELEASE        19 MARCH 2013 4.35 P.M.
 EET


In  its organising meeting,  the Board of  Directors of Orion Corporation, which
was  elected  today  by  the  Annual  General  Meeting  of the Shareholders, has
elected Jukka  Ylppö as Vice Chairman. The  compositions of the Board committees
were decided to be as follows:

Remuneration Committee:
Hannu Syrjänen, Chairman
Timo Maasilta
Heikki Westerlund

Audit Committee:
Heikki Westerlund, Chairman
Eero Karvonen
Timo Maasilta
Jukka Ylppö

R&D Committee:
Sirpa Jalkanen, Chairman
Eero Karvonen
Timo Maasilta
Hannu Syrjänen
Heikki Westerlund
Jukka Ylppö


The members to the Nomination Committee will be elected later.

The  Board  of  Directors  has  assessed  the  independence  of  its members and
concluded  that  all  the  members  are  independent  of  the  company  and  its
significant shareholders.



Orion Corporation




 Timo Lappalainen    Olli Huotari
 President and CEO   Senior VP, Corporate Functions






Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion  is a  globally operating  Finnish company  developing pharmaceuticals and
diagnostic  tests -  a builder  of well-being.  Orion develops, manufactures and
markets  human and veterinary pharmaceuticals, active pharmaceutical ingredients
and  diagnostic  tests.  The  company  is  continuously developing new drugs and
treatment  methods. Pharmaceutical R&D focuses  on central nervous system drugs,
oncology and critical care drugs, and Easyhaler® pulmonary drugs.

Orion's  net sales in 2012 amounted to EUR 980 million and the company had about
3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.


[HUG#1686277]